Galapagos Nv share price today

(GLPG)

Galapagos Nv share price is $27.07 & ₹2,293.64 as on 5 Dec 2024, 2.30 'hrs' IST

$27.07

▲

-0.42

(-1.53%)

Market is closed - opens 8 PM, 05 Dec 2024

View live Galapagos Nv share price in Dollar and Rupees. Guide to invest in Galapagos Nv from India. Also see the sentimental analysis on Indian investors investing in Galapagos Nv. Get details on the Indian mutual funds that are investing in Galapagos Nv. Get Analyst recommendations and forecasts along with all the Galapagos Nv's financials.

Galapagos Nv share price movements

$26.95
$27.30
$27.07
0.46%
Downside
Day's Volatility :1.3%
Upside
0.84%
$24.16
$42.46
$27.07
10.75%
Downside
52 Weeks Volatility :43.09%
Upside
36.24%

Galapagos Nv Returns

Period	Galapagos Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.64%	-4.7%	0.0%
6 Months	3.48%	0.9%	0.0%
1 Year	-28.52%	11.6%	0.0%
3 Years	-43.28%	12.9%	-18.1%

Galapagos Nv Key Statistics

in dollars & INR

Previous Close	$27.49
Open	$27.25
Today's High	$27.3
Today's Low	$26.945
Market Capitalization	$1.8B
Today's Volume	$110.1K
52 Week High	$42.455
52 Week Low	$24.16
Revenue TTM	$260.1M
EBITDA	$-136.0M
Earnings Per Share (EPS)	$-0.97
Profit Margin	79.33%
Quarterly Earnings Growth YOY	0.75%
Return On Equity TTM	-2.21%

How to invest in Galapagos Nv from India?

It is very easy for Indian residents to invest directly in Galapagos Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galapagos Nv stock in both rupees (INR) and dollars (USD). Search for Galapagos Nv or GLPG on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galapagos Nv or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galapagos Nv shares which would translate to 0.031 fractional shares of Galapagos Nv as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Galapagos Nv

200%

Period: Sep 5, 2024 to Dec 4, 2024. Change in 30 Days versus previous period

Search volume for Galapagos Nv on INDmoney from India has grown in the last 30 days as on Dec 5, 2024. 200% more investors are searching Galapagos Nv in the last 30 days versus the previous period.

Global Institutional Holdings in Galapagos Nv

FMR Inc
2.43%
Bvf Inc
2.38%
Deerfield Management Co
2.14%
Prosight Management, LP
1.56%
Logos Global Management LP
1.21%
PRIMECAP Management Company
1.09%

Analyst Recommendation on Galapagos Nv

Hold

38%Buy

61%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Galapagos Nv(by analysts ranked 0 to 5 stars)

Based on 18 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Galapagos Nv

What analysts predicted

Upside of 4.04%

Current:

$27.07

Target:

$28.16

Insights on Galapagos Nv

Decreasing Revenue
Revenue is down for the last 2 quarters, 77.87M → 59.84M (in $), with an average decrease of 23.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 157.55M → -50.43M (in $), with an average decrease of 264.7% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.5% return, outperforming this stock by 76.3%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.6% return, outperforming this stock by 88.1%

Galapagos Nv Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$328.6M	↑ 127.27%
Net Income	$-33.3M	↓ 74.71%
Net Profit Margin	-10.13%	↑ 80.91%

	FY19	Y/Y Change
Revenue	$939.0M	↑ 192.55%
Net Income	$166.5M	↓ 612.13%
Net Profit Margin	17.73%	↑ 27.86%

	FY20	Y/Y Change
Revenue	$581.5M	↓ 43.42%
Net Income	$-378.3M	↓ 307.55%
Net Profit Margin	-65.06%	↓ 82.79%

	FY21	Y/Y Change
Revenue	$548.1M	↑ 1.42%
Net Income	$-141.8M	↓ 59.67%
Net Profit Margin	-25.87%	↑ 39.19%

	FY22	Y/Y Change
Revenue	$534.7M	↑ 4.21%
Net Income	$-230.7M	↑ 73.81%
Net Profit Margin	-43.14%	↓ 17.27%

	FY23	Y/Y Change
Revenue	$261.5M	↓ 52.56%
Net Income	$230.9M	↓ 197.11%
Net Profit Margin	88.31%	↑ 131.45%

	Q2 FY23	Q/Q Change
Revenue	$162.7M	↓ 16.17%
Net Income	$5.5M	↓ 78.02%
Net Profit Margin	3.4%	↓ 9.57%

	Q3 FY23	Q/Q Change
Revenue	$128.1M	↓ 19.96%
Net Income	$27.6M	↑ 406.37%
Net Profit Margin	21.52%	↑ 18.12%

	Q4 FY23	Q/Q Change
Revenue	$-228.1M	↓ 274.23%
Net Income	$171.9M	↑ 509.98%
Net Profit Margin	-75.34%	↓ 96.86%

	Q1 FY24	Q/Q Change
Revenue	$67.9M	↓ 129.85%
Net Income	$98.1M	↓ 42.74%
Net Profit Margin	144.51%	↑ 219.85%

	Q2 FY24	Q/Q Change
Revenue	$83.8M	↑ 24.73%
Net Income	$9.7M	↓ 90.04%
Net Profit Margin	11.54%	↓ 132.97%

	Q3 FY24	Q/Q Change
Revenue	$59.8M	↓ 23.15%
Net Income	$-50.4M	↓ 661.27%
Net Profit Margin	-84.26%	↓ 95.8%

	FY18	Y/Y Change
Total Assets	$1.6B	↑ 11.91%
Total Liabilities	$256.2M	↓ 17.88%

	FY19	Y/Y Change
Total Assets	$6.7B	↑ 321.58%
Total Liabilities	$3.5B	↑ 1317.53%

	FY20	Y/Y Change
Total Assets	$7.0B	↓ 5.78%
Total Liabilities	$3.7B	↓ 4.56%

	FY21	Y/Y Change
Total Assets	$5.9B	↓ 9.17%
Total Liabilities	$2.9B	↓ 16.33%

	FY22	Y/Y Change
Total Assets	$5.0B	↓ 8.83%
Total Liabilities	$2.3B	↓ 13.39%

	FY23	Y/Y Change
Total Assets	$4.8B	↓ 7.96%
Total Liabilities	$1.7B	↓ 29.28%

	Q2 FY23	Q/Q Change
Total Assets	$4.9B	↓ 2.37%
Total Liabilities	$2.1B	↓ 6.25%

	Q3 FY23	Q/Q Change
Total Assets	$4.8B	↓ 1.57%
Total Liabilities	$2.0B	↓ 5.6%

	Q4 FY23	Q/Q Change
Total Assets	$4.8B	↓ 2.11%
Total Liabilities	$1.7B	↓ 14.64%

	Q1 FY24	Q/Q Change
Total Assets	$4.7B	↑ 0.09%
Total Liabilities	$1.6B	↓ 6.11%

	Q2 FY24	Q/Q Change
Total Assets	$4.6B	↓ 1.63%
Total Liabilities	$1.5B	↓ 5.89%

	Q3 FY24	Q/Q Change
Total Assets	$4.2B	↓ 2.75%
Total Liabilities	$1.3B	↓ 5.1%

	FY18	Y/Y Change
Operating Cash Flow	$-162.1M	↓ 3.1%
Investing Cash Flow	$-18.1M	↑ 2798.72%
Financing Cash Flow	$327.5M	↓ 18.53%

	FY19	Y/Y Change
Operating Cash Flow	$3.6B	↓ 2352.2%
Investing Cash Flow	$-4.2B	↑ 23556.28%
Financing Cash Flow	$1.5B	↑ 364.0%

	FY20	Y/Y Change
Operating Cash Flow	$-519.8M	↓ 113.32%
Investing Cash Flow	$921.1M	↓ 120.12%
Financing Cash Flow	$26.8M	↓ 98.35%

	FY21	Y/Y Change
Operating Cash Flow	$-569.6M	↑ 17.9%
Investing Cash Flow	$611.8M	↓ 28.53%
Financing Cash Flow	$-4.4M	↓ 117.59%

	FY22	Y/Y Change
Operating Cash Flow	$-529.7M	↓ 0.65%
Investing Cash Flow	$-1.3B	↓ 330.12%
Financing Cash Flow	$-1.6M	↓ 61.64%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-136.0M	↑ 32.2%
Investing Cash Flow	$198.0M	↑ 0.0%
Financing Cash Flow	$-1.7M	↑ 716.32%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-126.8M	↓ 5.26%
Investing Cash Flow	$194.9M	↑ 0.0%
Financing Cash Flow	$-2.2M	↑ 33.4%

Galapagos Nv Technicals Summary

Sell

Neutral

Buy

Galapagos Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Galapagos Nv Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Galapagos Nv	4.67%	3.48%	-28.52%	-43.28%	-87.03%
Regeneron Pharmaceuticals, Inc.	-8.09%	-23.83%	-8.78%	21.97%	108.5%
Biontech Se	5.61%	15.12%	15.65%	-58.12%	304.14%
Alnylam Pharmaceuticals, Inc.	-4.63%	69.46%	44.56%	42.94%	109.6%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.08%	31.76%	127.12%	112.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Galapagos Nv	50.85	NA	0.0	0.35	-0.02	-0.02	NA	43.41
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Galapagos Nv	Hold	$1.8B	-87.03%	50.85	79.33%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	108.5%	18.55	33.61%
Biontech Se	Buy	$28.9B	304.14%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	109.6%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	112.3%	32.84	-4.51%

About Galapagos Nv

Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.

Organization	Galapagos Nv
Employees	1123
CEO	Dr. Paulus A. Stoffels M.D., Ph.D.
Industry	Health Technology

Management People of Galapagos Nv

Name	Title
Dr. Paulus A. Stoffels M.D., Ph.D.	CEO, Chairman, Interim Head of R&D
Mr. Thad Huston C.M.A.	Executive VP, CFO & COO
Ms. Sofie Van Gijsel	Head of Investor Relations
Ms. Valeria Cnossen	Executive VP & General Counsel
Marieke Vermeersch	Head of Corporate Communication
Ms. Annelies Missotten	Executive VP & Chief Human Resources Officer
Ms. Ellen Van Der Aar	Head of Development
Mr. Philippe Alen M.B.A., Ph.D., Pharm.D.	Senior VP & Head of Business Development
Ms. Alice Dietrich	Head of Medical Affairs
Dr. Pierre J.M.B. Raboisson Ph.D., Pharm.D.	Head of Small Molecules Discovery & Senior VP

Important FAQs about investing in Galapagos Nv from India :

What is Galapagos Nv share price today?

Galapagos Nv (GLPG) share price today is $27.07.

Can Indians buy Galapagos Nv shares?

Yes, Indians can invest in the Galapagos Nv (GLPG) from India.

With INDmoney, you can buy Galapagos Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Galapagos Nv at zero transaction cost.

How can I buy Galapagos Nv shares from India?

It is very easy to buy Galapagos Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galapagos Nv be purchased?

Yes, you can buy fractional shares of Galapagos Nv with INDmoney app.

What are the documents required to start investing in Galapagos Nv stocks?

To start investing in Galapagos Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.